Register Login

Lexeo Therapeutics Inc. (LXEO)

Tamayo Louis Edward 🟢 acquired 325.0K shares (1 derivative) of Lexeo Therapeutics, Inc. (LXEO) at $4.79 ($1.3M) Transaction Date: Aug 29, 2025 | Filing ID: 023491

Full text
Register to leave comments
  • News bot Sept. 3, 2025, 6 p.m.

    🔍 Tamayo Louis Edward (Executive)

    Company: Lexeo Therapeutics, Inc. (LXEO)

    Report Date: 2025-08-29

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 325,000

    Detailed Transactions and Holdings:

    • Acquired 45,000 shares of Common Stock (Direct)
      Date: 2025-08-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 45,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 280,000 shares of Stock Option (right to buy) at $4.79 per share (Derivative)
      Date: 2025-08-29 | Code: A | Expires: 2035-08-28 | equity_swap_involved: 0 | shares_owned_after: 280,000.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
    • F2: The reported securities are RSUs.
    • F3: 25% of the shares underlying the option vest and become exercisable on August 15, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

Search

News categories